World Library  
Flag as Inappropriate
Email this Article

Paracrine signalling

Article Id: WHEBN0000563093
Reproduction Date:

Title: Paracrine signalling  
Author: World Heritage Encyclopedia
Language: English
Subject: Cell signaling, Endocrine system, Hormone, Dopamine, Signal transduction
Collection: Signal Transduction
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Paracrine signalling

Paracrine signaling is a form of cell-cell communication in which a cell produces a signal to induce changes in nearby cells, altering the behavior or differentiation of those cells. Signaling molecules known as paracrine factors diffuse over a relatively short distance (local action), as opposed to endocrine factors (hormones which travel considerably longer distances via the circulatory system), juxtacrine interactions, and autocrine signaling. Cells that produce paracrine factors secrete them into the immediate extracellular environment. Factors then travel to nearby cells in which the gradient of factor received determines the outcome. However, the exact distance that paracrine factors can travel is not certain.

Overview of signal transduction pathways.

Although paracrine signaling elicits a diverse array of responses in the induced cells, most paracrine factors utilize a relatively streamlined set of Fibroblast growth factor (FGF) family, Hedgehog family, Wnt family, and TGF-β superfamily. Binding of a paracrine factor to its respective receptor initiates signal transduction cascades, eliciting different responses.

Contents

  • Paracrine Factors Induce Competent Responders 1
  • Fibroblast Growth Factor (FGF) family 2
    • Receptor Tyrosine Kinase (RTK) pathway 2.1
      • RTK receptor and cancer 2.1.1
      • RTK pathway and cancer 2.1.2
    • Jak-STAT pathway 2.2
      • Aberrant Jak-STAT pathway and bone mutations 2.2.1
      • Jak-STAT pathway and cancer 2.2.2
  • Hedgehog family 3
    • Hedgehog signaling pathway 3.1
    • Hedgehog signaling pathway and cancer 3.2
  • Wnt family 4
    • The canonical Wnt signaling pathway 4.1
    • The noncanonical Wnt signaling pathways 4.2
      • The noncanonical Planar Cell Polarity (PCP) pathway 4.2.1
      • The noncanonical Wnt/Ca2+ pathway 4.2.2
    • Wnt signaling pathways and cancer 4.3
  • TGF-β superfamily 5
    • TGF-β pathway 5.1
    • SMAD pathway 5.2
    • Non-SMAD pathway 5.3
    • Members of TGF-β superfamily 5.4
      • 1. TGF-β family 5.4.1
      • 2. Bone Morphogenetic Protein (BMPs) family 5.4.2
      • Other members of TFG-β superfamily 5.4.3
    • Summary table of TFG-β signaling pathway 5.5
  • Examples 6
  • See also 7
  • References 8
  • External links 9

Paracrine Factors Induce Competent Responders

In order for paracrine factors to successfully induce a response in the receiving cell, that cell must have the appropriate receptors available on the cell membrane to receive the signals, also known as being competent. Additionally, the responding cell must also have the ability to be mechanistically induced.

Fibroblast Growth Factor (FGF) family

Although the FGF family of paracrine factors has a broad range of functions, major findings support the idea that they primarily stimulate proliferation and differentiation.[1][2] To fulfill many diverse functions, FGFs can be alternatively spliced or even have different initiation codons to create hundred of different FGF isoforms.[3]

One of the most important functions of the FGF receptors (FGFR) is in limb development. This signaling involves nine different alternatively spliced isoforms of the receptor.[4] Fgf8 and Fgf10 are two of the critical players in limb development. In the forelimb initiation and limb growth in mice, axial cues from the intermediate mesoderm produces Tbx5, which subsequently signals to the same mesoderm to produce Fgf10. Fgf10 then signals to the ectoderm to begin production of Fgf8, which also stimulates the production of Fgf10. Deletion of Fgf10 results in limbless mice.[5]

Additionally, paracrine signaling of Fgf is essential in the developing eye of chicks. The fgf8 mRNA becomes localized in what differentiates into the neural retina of the optic cup. These cells are in contact with the outer ectoderm cells, which will eventually become the lens.[3]

Phenotype

and survival of mice after knockout of some FGFR genes:[4]

FGFR Knockout Gene Survival Phenotype
Fgf1 Viable Unclear
Fgf3 Viable Inner ear, skeletal (tail) differentiation
Fgf4 Lethal Inner cell mass proliferation
Fgf8 Lethal Gastrulation defect, CNS development, limb development
Fgf10 Lethal Development of multiple organs (including limbs, thymus, pituitary)
Fgf17 Viable Cerebellar Development

Receptor Tyrosine Kinase (RTK) pathway

Paracrine signaling through fibroblast growth factors and its respective receptors utilizes the receptor tyrosine pathway. This signaling pathway has been highly studied, using Drosophila eyes and human cancers.[6]

Binding of FGF to FGFR phosphorylates the idle kinase and activates the RTK pathway. This pathway begins at the cell membrane surface, where a ligand binds to its specific receptor. Ligands that bind to RTKs include fibroblast growth factors, epidermal growth factors, platelet-derived growth factors, and stem cell factor.[6] This dimerizes the transmembrane receptor to another RTK receptor, which causes the autophosphorylation and subsequent conformational change of the homodimerized receptor. This conformational change activates the dormant kinase of each RTK on the tyrosine residue. Due to the fact that the receptor spans across the membrane from the extracellular environment, through the lipid bilayer, and into the cytoplasm, the binding of the receptor to the ligand also causes the transphosphorylation of the cytoplasmic domain of the receptor.[7]

An adaptor protein (such as SOS) recognizes the phosphorylated tyrosine on the receptor. This protein functions as a bridge which connects the RTK to an intermediate protein (such as GNRP), starting the intracellular signaling cascade. In turn, the intermediate protein stimulates GDP-bound Ras to the activated GTP-bound Ras. GAP eventually returns Ras to its inactive state. Activation of Ras has the potential to initiate three signaling pathways downstream of Ras: Ras→Raf→MAP kinase pathway, PI3 kinase pathway, and Ral pathway. Each pathway leads to the activation of transcription factors which enter the nucleus to alter gene expression.[8]

Diagram showing key components of a signal transduction pathway. See the MAPK/ERK pathway article for details.

RTK receptor and cancer

Paracrine signaling of growth factors between nearby cells has been shown to exacerbate carcinogenesis. In fact, mutant forms of a single RTK may play a causal role in very different types of cancer. The Kit proto-oncogene encodes a tyrosine kinase receptor whose ligand is a paracrine protein called stem cell factor (SCF), which is important in hematopoiesis (formation of cells in blood).[9] The Kit receptor and related tyrosine kinase receptors actually are inhibitory and effectively suppresses receptor firing. Mutant forms of the Kit receptor, which fire constitutively in a ligand-independent fashion, are found in a diverse array of cancerous malignancies.[10]

RTK pathway and cancer

Research on thyroid cancer has elucidated the theory that paracrine signaling may aid in creating tumor microenvironments. Chemokine transcription is upregulated when Ras is in the GTP-bound state. The chemokines are then released from the cell, free to bind to another nearby cell. Paracrine signaling between neighboring cells creates this positive feedback loop. Thus, the constitutive transcription of upregulated proteins form ideal environments for tumors to arise.[11] Effectively, multiple bindings of ligands to the RTK receptors overstimulates the Ras-Raf-MAPK pathway, which overexpresses the mitogenic and invasive capacity of cells.[12]

Jak-STAT pathway

In addition to RTK pathway, fibroblast growth factors can also activate the Jak-STAT signaling cascade. Instead of carrying covalently associated tyrosine kinase domains, Jak-STAT receptors form noncovalent complexes with tyrosine kinases of the Jak (Janus kinase) class. These receptors bind are for erythropoietin (important for erythropoiesis), thrombopoietin (important for platelet formation), and interferon (important for mediating immune cell function).[13]

After dimerization of the cytokine receptors following ligand binding, the Jaks transphosphorylate each other. The resulting phosphotyrosines attract STAT proteins. The STAT proteins dimerize and enter the nucleus to act as transcription factors to alter gene expression.[13] In particular, the STATS transcribe genes that aid in cell proliferation and survival – such as myc.[14]

Phenotype and survival of mice after knockout of some Jak or STAT genes:[15]

Knockout Gene Survival Phenotype
Jak1 Lethal Neurologic Deficits
Jak2 Lethal Failure in erythropoiesis
Stat1 Viable Human dwarfism and craniosynostosis syndromes
Stat3 Lethal Tissue specific phenotypes
Stat4 Viable defective IL-12-driven Th1 differentiation, increased susceptibility to intracellular pathogens

Aberrant Jak-STAT pathway and bone mutations

The Jak-STAT pathway is instrumental in the development of limbs, specifically in its ability to regulate bone growth through paracrine signaling of cytokines. However, mutations in this pathway have been implicated in severe forms of dwarfism: thanatophoric dysplasia (lethal) and achondroplasic dwarfism (viable).[16] This is due to a mutation in a Fgf gene, causing a premature and constitutive activation of the Stat1 transcription factor. Chondrocyte cell division is prematurely terminated, resulting in lethal dwarfism. Rib and limb bone growth plate cells are not transcribed. Thus, the inability of the rib cage to expand prevents the newborn's breathing.[17]

Jak-STAT pathway and cancer

Research on paracrine signaling through the Jak-STAT pathway revealed its potential in activating invasive behavior of ovarian epithelial cells. This epithelial to mesenchymal transition is highly evident in metastasis.[18] Paracrine signaling through the Jak-STAT pathway is necessary in the transition from stationary epithelial cells to mobile mesenchymal cells, which are capable of invading surrounding tissue. Only the Jak-STAT pathway has been found to induce migratory cells.[19]

Hedgehog family

The somite polarity. Desert hedgehog (DHH) is expressed in the Sertoli cells involved in spermatogenesis. Indian hedgehog (IHH) is expressed in the gut and cartilage, important in postnatal bone growth.[20][21][22]

Hedgehog signaling pathway

Production of the CiR transcriptional repressor when Hh is not bound to Patched. In the diagram, "P" represents phosphate.
When Hh is bound to Patched (PTCH), Ci protein is able to act as a transcription factor in the nucleus.

Members of the Hedgehog protein family act by binding to a transmembrane "Patched" receptor, which is bound to the "Smoothened" protein, by which the Hedgehog signal can be transduced. In the absence of Hedgehog, the Patched receptor inhibits Smoothened action. Inhibition of Smoothened causes the Cubitus interruptus (Ci), Fused, and Cos protein complex attached to microtubules to remain intact. In this conformation, the Ci protein is cleaved so that a portion of the protein is allowed to enter the nucleus and act as a transcriptional repressor. In the presence of Hedgehog, Patched no longer inhibits Smoothened. Then active Smoothened protein is able to inhibit PKA and Slimb, so that the Ci protein is not cleaved. This intact Ci protein can enter the nucleus, associate with CPB protein and act as a transcriptional activator, inducing the expression of Hedgehog-response genes.[22][23][24]

Hedgehog signaling pathway and cancer

The Hedgehog Signaling pathway is critical in proper tissue patterning and orientation during normal development of most animals. Hedgehog proteins induce tumorigenesis via the Hedgehog pathway.[25][26][27]

Wnt family

Figure of the three main pathways of Wnt signaling in biological signal transduction.

The cell proliferation, cell morphology, cell motility, and cell fate.[28]

The canonical Wnt signaling pathway

Canonical Wnt pathway without Wnt.

In the canonical pathway, Wnt proteins binds to its transmembrane receptor of the Frizzled family of proteins. The binding of Wnt to a Frizzled protein activates the Dishevelled protein. In its active state the Dishevelled protein inhibits the activity of the glycogen synthase kinase 3 (GSK3) enzyme. Normally active GSK3 prevents the dissociation of β-catenin to the APC protein, which results in β-catenin degradation. Thus inhibited GSK3, allows β-catenin to dissociate from APC, accumulate, and travel to nucleus. In the nucleus β-catenin associates with Lef/Tcf transcription factor, which is already working on DNA as a repressor, inhibiting the transcription of the genes it binds. Binding of β-catenin to Lef/Tcf works as a transcription activator, activating the transcription of the Wnt-responsive genes.[29][30][31]

The noncanonical Wnt signaling pathways

The noncanonical Wnt pathways provide a signal transduction pathway for Wnt that does not involve β-catenin. In the noncanonical pathways, Wnt affects the actin and microtubular cytoskeleton as well as gene transcription.

The noncanonical Planar Cell Polarity (PCP) pathway

Noncanonical Wnt Planar Cell Polarity pathway.

The noncanonical PCP pathway regulates cell morphology, division, and movement. Once again Wnt proteins binds to and activates Frizzled so that Frizzled activates a Dishevelled protein that is tethered to the plasma membrane through a Prickle protein and transmembrane Stbm protein. The active Dishevelled activates RhoA GTPase through Dishevelled associated activator of morphogenesis 1 (Daam1) and the Rac protein. Active RhoA is able to induce cytoskeleton changes by activating Roh-associated kinase (ROCK) and affect gene transcription directly. Active Rac can directly induce cytoskeleton changes and affect gene transcription through activation of JNK.[29][30][31]

The noncanonical Wnt/Ca2+ pathway

Noncanonical Wnt/calcium pathway.

The noncanonical Wnt/Ca2+ pathway regulates intracellular calcium levels. Again Wnt binds and activates to Frizzled. In this case however activated Frizzled causes a coupled G-protein to activate a phospholipase (PLC), which interacts with and splits PIP2 into DAG and IP3. IP3 can then bind to a receptor on the endoplasmic reticulum to release intracellular calcium stores, to induce calcium-dependent gene expression.[29][30][31]

Wnt signaling pathways and cancer

The Wnt signaling pathways are critical in cell-cell signaling during normal development and embryogenesis and required for maintenance of adult tissue, therefore it is not difficult to understand why disruption in Wnt signaling pathways can promote human degenerative disease and cancer.

The Wnt signaling pathways are complex, involving many different elements, and therefore have many targets for misregulation. Mutations that cause constitutive activation of the Wnt signaling pathway lead to tumor formation and cancer. Aberrant activation of the Wnt pathway can lead to increase cell proliferation. Current research is focused on the action of the Wnt signaling pathway the regulation of stem cell choice to proliferate and self renew. This action of Wnt signaling in the possible control and maintenance of stem cells, may provide a possible treatment in cancers exhibiting aberrant Wnt signaling.[32][33][34]

TGF-β superfamily

External links

  1. ^ Gospodarowicz, D.; Ferrara, N.; Schweigerer, L.; Neufeld, G. (1987). "Structural Characterization and Biological Functions of Fibroblast Growth Factor". Endocrine Reviews 8 (2): 95–114.  
  2. ^ Rifkin, Daniel B.; Moscatelli, David (1989). "Recent developments in the cell biology of basic fibroblast growth factor". The Journal of Cell Biology 109 (1): 1–6.  
  3. ^ a b Lappi, Douglas A. (1995). "Tumor targeting through fibroblast growth factor receptors". Seminars in Cancer Biology 6 (5): 279–88.  
  4. ^ a b Xu, J.; Xu, J; Colvin, JS; McEwen, DG; MacArthur, CA; Coulier, F; Gao, G; Goldfarb, M (1996). "Receptor Specificity of the Fibroblast Growth Factor Family". Journal of Biological Chemistry 271 (25): 15292–7.  
  5. ^ Logan, M. (2003). "Finger or toe: The molecular basis of limb identity". Development 130 (26): 6401–10.  
  6. ^ a b Fantl, Wendy J; Johnson, Daniel E; Williams, Lewis T (1993). "Signaling by Receptor Tyrosine  
  7. ^ Yarden, Yosef; Ullrich, Axel (1988). "Growth Factor Receptor Tyrosine Kinases". Annual Review of Biochemistry 57: 443–78.  
  8. ^ Katz, Michael E; McCormick, Frank (1997). "Signal transduction from multiple Ras effectors". Current Opinion in Genetics & Development 7 (1): 75–9.  
  9. ^ Zsebo, Krisztina M.; Williams, David A.; Geissler, Edwin N.; Broudy, Virginia C.; Martin, Francis H.; Atkins, Harry L.; Hsu, Rou-Yin; Birkett, Neal C.; Okino, Kenneth H.; Murdock, Douglas C.; Jacobsen, Frederick W.; Langley, Keith E.; Smith, Kent A.; Takeish, Takashi; Cattanach, Bruce M.; Galli, Stephen J.; Suggs, Sidney V. (1990). "Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor". Cell 63 (1): 213–24.  
  10. ^ Rönnstrand, L. (2004). "Signal transduction via the stem cell factor receptor/c-Kit". Cellular and Molecular Life Sciences 61 (19–20): 2535–48.  
  11. ^ Melillo, Rosa Marina; Castellone, Maria Domenica; Guarino, Valentina; De Falco, Valentina; Cirafici, Anna Maria; Salvatore, Giuliana; Caiazzo, Fiorina; Basolo, Fulvio; Giannini, Riccardo; Kruhoffer, Mogens; Orntoft, Torben; Fusco, Alfredo; Santoro, Massimo (2005). "The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells". Journal of Clinical Investigation 115 (4): 1068–81.  
  12. ^ Kolch, Walter (2000). "Meaningful relationships: The regulation of the Ras/Raf/MEK/ERK pathway by protein interactions". The Biochemical journal 351 (2): 289–305.  
  13. ^ a b Aaronson, David S.; Horvath, Curt M. (2002). "A Road Map for Those Who Don't Know JAK-STAT". Science 296 (5573): 1653–5.  
  14. ^ Rawlings, Jason S.; Rosler, Kristin M.; Harrison, Douglas A. (2004). "The JAK/STAT signaling pathway". Journal of Cell Science 117 (8): 1281–3.  
  15. ^ O'Shea, John J; Gadina, Massimo; Schreiber, Robert D (2002). "Cytokine signaling in 2002: new surprises in the Jak/Stat pathway". Cell 109 (2): S121–31.  
  16. ^ Bonaventure, J.; Rousseau, F.; Legeai-Mallet, L.; Le Merrer, M.; Munnich, A.; Maroteaux, P. (1996). "Common mutations in the fibroblast growth factor receptor 3 (FGFR3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism". American Journal of Medical Genetics 63 (1): 148–54.  
  17. ^ Shiang, Rita; Thompson, Leslie M.; Zhu, Ya-Zhen; Church, Deanna M.; Fielder, Thomas J.; Bocian, Maureen; Winokur, Sara T.; Wasmuth, John J. (1994). "Mutations in the transmembrane domain of  
  18. ^ Kalluri, Raghu; Weinberg, Robert A. (2009). "The basics of epithelial-mesenchymal transition". Journal of Clinical Investigation 119 (6): 1420–8.  
  19. ^ Silver, Debra L.; Montell, Denise J. (2001). "Paracrine Signaling through the JAK/STAT Pathway Activates Invasive Behavior of Ovarian Epithelial Cells in Drosophila". Cell 107 (7): 831–41.  
  20. ^ Ingham, P. W.; McMahon, AP (2001). "Hedgehog signaling in animal development: Paradigms and principles". Genes & Development 15 (23): 3059–87.  
  21. ^ Bitgood, Mark J.; McMahon, Andrew P. (1995). "Hedgehog and Bmp Genes Are Coexpressed at Many Diverse Sites of Cell–Cell Interaction in the Mouse Embryo". Developmental Biology 172 (1): 126–38.  
  22. ^ a b Jacob, L.; Lum, L. (2007). "Hedgehog Signaling Pathway". Science's STKE 2007 (407): cm6.  
  23. ^ Johnson, Ronald L; Scott, Matthew P (1998). "New players and puzzles in the Hedgehog signaling pathway". Current Opinion in Genetics & Development 8 (4): 450–6.  
  24. ^ Nybakken, K; Perrimon, N (2002). "Hedgehog signal transduction: Recent findings". Current Opinion in Genetics & Development 12 (5): 503–11.  
  25. ^ Collins, R. T.; Cohen, SM (2005). "A Genetic Screen in Drosophila for Identifying Novel Components of the Hedgehog Signaling Pathway". Genetics 170 (1): 173–84.  
  26. ^ Evangelista, M.; Tian, H.; De Sauvage, F. J. (2006). "The Hedgehog Signaling Pathway in Cancer". Clinical Cancer Research 12 (20): 5924–8.  
  27. ^ Taipale, Jussi; Beachy, Philip A. (2001). "The Hedgehog and Wnt signaling pathways in cancer". Nature 411 (6835): 349–54.  
  28. ^ Cadigan, K. M.; Nusse, R. (1997). "Wnt signaling: A common theme in animal development". Genes & Development 11 (24): 3286–305.  
  29. ^ a b c Dale, Trevor C. (1998). "Signal transduction by the Wnt family of ligands". The Biochemical journal 329 (Pt 2): 209–23.  
  30. ^ a b c Chen, Xi; Yang, Jun; Evans, Paul M; Liu, Chunming (2008). "Wnt signaling: The good and the bad". Acta Biochimica et Biophysica Sinica 40 (7): 577–94.  
  31. ^ a b c Komiya, Yuko; Habas, Raymond (2008). "Wnt signal transduction pathways". Organogenesis 4 (2): 68–75.  
  32. ^ Logan, Catriona Y.; Nusse, Roel (2004). "The Wnt Signaling Pathway in Development and Disease". Annual Review of Cell and Developmental Biology 20: 781–810.  
  33. ^ Lustig, B; Behrens, J (2003). "The Wnt signaling pathway and its role in tumor development". Journal of cancer research and clinical oncology 129 (4): 199–221.  
  34. ^ Neth, Peter; Ries, Christian; Karow, Marisa; Egea, Virginia; Ilmer, Matthias; Jochum, Marianne (2007). "The Wnt Signal Transduction Pathway in Stem Cells and Cancer Cells: Influence on Cellular Invasion". Stem Cell Reviews 3 (1): 18–29.  
  35. ^ a b c Bandyopadhyay, Amitabha; Tsuji, Kunikazu; Cox, Karen; Harfe, Brian D.; Rosen, Vicki; Tabin, Clifford J. (2006). "Genetic Analysis of the Roles of BMP2, BMP4, and BMP7 in Limb Patterning and Skeletogenesis". PLoS Genetics 2 (12): e216.  
  36. ^ Attisano, Liliana; Wrana, Jeffrey L. (2002). "Signal Transduction by the TGF-β Superfamily". Science 296 (5573): 1646–7.  
  37. ^ a b c Wrana, Jeffrey L.; Ozdamar, Barish; Le Roy, Christine; Benchabane, Hassina (2008). "Signaling Receptors of the TGF-β Family". In Derynck, Rik; Miyazono, Kohei. The TGF-β Family. pp. 151–77.  
  38. ^ ten Dijke, Peter; Heldin, Carl-Henrik (2006). "The Smad family". In ten Dijke, Peter; Heldin, Carl-Henrik. Smad Signal Transduction: Smads in Proliferation, Differentiation and Disease. Proteins and Cell Regulation 5. Dordrecht: Springer. pp. 1–13.  
  39. ^ Moustakas, Aristidis (2002-09-01). "Smad signaling network". Journal of Cell Science 115 (17): 3355–6.  
  40. ^ Wu, Jia-Wei; Hu, Min; Chai, Jijie; Seoane, Joan; Huse, Morgan; Li, Carey; Rigotti, Daniel J.; Kyin, Saw; Muir, Tom W.; Fairman, Robert; Massagué, Joan; Shi, Yigong (2001). "Crystal Structure of a Phosphorylated Smad2". Molecular Cell 8 (6): 1277–89.  
  41. ^ Pavletich, Nikola P.; Hata, Yigong; Lo, Akiko; Massagué, Roger S.; Pavletich, Joan (1997). "A structural basis for mutational inactivation of the tumour suppressor Smad4". Nature 388 (6637): 87–93.  
  42. ^ Itoh, Fumiko; Asao, Hironobu; Sugamura, Kazuo; Heldin, Carl-Henrik; Ten Dijke, Peter; Itoh, Susumu (2001). "Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads". The EMBO Journal 20 (15): 4132–42.  
  43. ^ Schmierer, Bernhard; Hill, Caroline S. (2007). "TGFβ–SMAD signal transduction: Molecular specificity and functional flexibility". Nature Reviews Molecular Cell Biology 8 (12): 970–82.  
  44. ^ Moustakas, Aristidis; Heldin, Carl-Henrik (2005). "Non-Smad TGF-β signals". Journal of Cell Science 118 (16): 3573–84.  
  45. ^ Ohkawara, Bisei; Iemura, Shun-Ichiro; Ten Dijke, Peter; Ueno, Naoto (2002). "Action Range of BMP is Defined by Its N-Terminal Basic Amino Acid Core". Current Biology 12 (3): 205–9.  
  46. ^ Munir, Sadia; Xu, Guoxiong; Wu, Yaojiong; Yang, Burton; Lala, Peeyush K.; Peng, Chun (2004). "Nodal and ALK7 Inhibit Proliferation and Induce Apoptosis in Human Trophoblast Cells". Journal of Biological Chemistry 279 (30): 31277–86.  
  47. ^ Duester, Gregg (September 2008). "Retinoic acid synthesis and signaling during early organogenesis". Cell 134 (6): 921–31.  

References

See also

In mature organisms, paracrine signaling is involved in responses to allergens, tissue repair, the formation of scar tissue, and blood clotting.

Growth factor and clotting factors are paracrine signaling agents. The local action of growth factor signaling plays an especially important role in the development of tissues. Also, retinoic acid, the active form of vitamin A, functions in a paracrine fashion to regulate gene expression during embryonic development in higher animals.[47] In insects, Allatostatin controls growth though paracrine action on the corpora allata.

Examples

TGF Beta superfamily ligand Type II Receptor Type I Receptor R-SMADs Co-SMAD Ligand Inhibitors
Activin A ACVR2A ACVR1B (ALK4) SMAD2, SMAD3 SMAD4 Follistatin
GDF1 ACVR2A ACVR1B (ALK4) SMAD2, SMAD3 SMAD4
GDF11 ACVR2B ACVR1B (ALK4), TGFβRI (ALK5) SMAD2, SMAD3 SMAD4
Bone morphogenetic proteins BMPR2 BMPR1A (ALK3), BMPR1B (ALK6) SMAD1 SMAD5, SMAD8 SMAD4 Noggin, Chordin, DAN
Nodal ACVR2B ACVR1B (ALK4), ACVR1C (ALK7) SMAD2, SMAD3 SMAD4 Lefty
TGFβs TGFβRII TGFβRI (ALK5) SMAD2, SMAD3 SMAD4 LTBP1, THBS1, Decorin

Summary table of TFG-β signaling pathway

Other members of TFG-β superfamily

The BMPs bind to the bone morphogenetic protein receptor type II (BMPR2). Some of the proteins of the BMP family are BMP4 and BMP7. BMP4 promotes bone formation, causes cell death, or signals the formation of epidermis, depending on the tissue it is acting on. BMP7 is crucial for kidney development, sperm synthesis, and neural tube polarization. Both BMP4 and BMP7 regulate mature ligand stability and processing, including degrading ligands in lysosomes.[35] BMPs act by diffusing from the cells that create them.[45]

Members of the BMP family were originally found to induce bone formation, as their name suggests. However, BMPs are very multifunctional and can also regulate apoptosis, cell migration, cell division, and differentiation. They also specify the anterior/posterior axis, induce growth, and regulate homeostasis.[35]

2. Bone Morphogenetic Protein (BMPs) family

TGF-β1 stimulates the synthesis of collagen and fibronectin and inhibits the degradation of the extracellular matrix degradation. Ultimately, it increases the production of extracellular matrix by epithelial cells.[37] TGF-β proteins regulate epithelia by controlling where and when they branch to form kidney, lung, and salivary gland ducts.[37]

This family includes TGF-β1, TGF-β2, TGF-β3, and TGF-β5. They are involved in positively and negatively regulation of cell division, the formation of the extracellular matrix between cells, apoptosis, and embryogenesis. They bind to TGF-β type II receptor (TGFBRII).

1. TGF-β family

Members of TGF-β superfamily

Non-Smad signaling proteins contribute to the responses of the TGF-β pathway in three ways. First, non-Smad signaling pathways phosphorylate the Smads. Second, Smads directly signal to other pathways by communicating directly with other signaling proteins, such as kinases. Finally, the TGF-β receptors directly phosphorylate non-Smad proteins.[44]

Non-SMAD pathway

Specific TGF-β ligands will result in the activation of either the SMAD2/3 or the SMAD1/5 R-SMADs. For instance, when activin, Nodal, or TGF-β ligand binds to the receptors, the phosphorylated receptor complex can activate SMAD2 and SMAD3 through phosphorylation. However, when a BMP ligand binds to the receptors, the phosphorylated receptor complex activates SMAD1 and SMAD5. Then, the Smad2/3 or the Smad1/5 complexes form a dimer complex with SMAD4 and become transcription factors. Though there are many R-SMADs involved in the pathway, there is only one co-SMAD, SMAD4.[43]

The TGF-β Superfamily activates members of the SMAD family, which function as transcription factors. Specifically, the type I receptor, activated by the type II receptor, phosphorylates R-SMADs that then bind to the co-SMAD, SMAD4. The R-SMAD/Co-SMAD forms a complex with importin and enters the nucleus, where they act as transcription factors and either up-regulate or down-regulate in the expression of a target gene.

Class SMADs
R-SMAD SMAD1, SMAD2, SMAD3, SMAD5 and SMAD8/9
Co-SMAD SMAD4
I-SMAD SMAD6 and SMAD7

Examples of SMADs In Each Class:[40][41][42]

  1. Receptor-regulated SMAD (R-SMAD)
  2. Common-mediator SMAD (Co-SMAD)
  3. Inhibitory SMAD (I-SMAD)

There are three classes of SMADs:

SMAD pathway

SMAD Signaling Pathway Activated by TGF-β

The cell growth, differentiation, apoptosis, and homeostasis. There are five kinds of type II receptors and seven types of type I receptors in humans and other mammals. These receptors are known as “dual-specificity kinases” because their cytoplasmic kinase domain has weak tyrosine kinase activity but strong serine/threonine kinase activity.[38] When a TGF-β superfamily ligand binds to the type II receptor, it recruits a type I receptor and activates it by phosphorylating the serine or threonine residues of its “GS” box.[39] This forms an activation complex that can then phosphorylate SMAD proteins through phosphorylation.

TGF-β pathway

[37] ligands bind to either Type I or Type II receptors, to create heterotetramic complexes.TGF-β All [36]

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.